Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.3M Buy
216,325
+89,517
+71% +$6.38M 0.26% 38
2025
Q4
$7.83M Buy
126,808
+45,114
+55% +$2.66M 0.14% 59
2025
Q3
$4.8M Sell
81,694
-12,059
-13% -$703K 0.09% 79
2025
Q2
$5.46M Sell
93,753
-32,908
-26% -$1.86M 0.13% 71
2025
Q1
$6.29M Sell
126,661
-3,946
-3% -$202K 0.16% 61
2024
Q4
$5.84M Sell
130,607
-23,939
-15% -$1.14M 0.14% 63
2024
Q3
$7.43M Sell
154,546
-354,727
-70% -$17.1M 0.17% 55
2024
Q2
$25.9M Buy
509,273
+881
+0.2% +$48.2K 0.63% 20
2024
Q1
$27.6M Sell
508,392
-25,296
-5% -$1.32M 0.69% 20
2023
Q4
$30.1M Buy
533,688
+94,715
+22% +$5.35M 0.96% 17
2023
Q3
$27.1M Buy
438,973
+36,035
+9% +$2.28M 0.92% 22
2023
Q2
$23.8M Sell
402,938
-106,868
-21% -$6.8M 0.8% 17
2023
Q1
$37.1M Buy
509,806
+10,266
+2% +$792K 1.27% 13
2022
Q4
$36.5M Buy
499,540
+118,632
+31% +$9.37M 1.29% 13
2022
Q3
$31.8M Buy
380,908
+177,654
+87% +$15.3M 1.26% 11
2022
Q2
$16.2M Sell
203,254
-132,221
-39% -$12.8M 0.58% 29
2022
Q1
$34.9M Sell
335,475
-113,003
-25% -$9.36M 1.05% 13
2021
Q4
$33.7M Sell
448,478
-11,202
-2% -$784K 0.87% 20
2021
Q3
$29.8M Buy
459,680
+22,539
+5% +$1.38M 0.68% 20
2021
Q2
$26.5M Sell
437,141
-226,843
-34% -$13.4M 0.61% 27
2021
Q1
$35.8M Hold
663,984
0.89% 21
2020
Q4
$32M Sell
663,984
-52,318
-7% -$2.31M 0.82% 23
2020
Q3
$28.1M Buy
716,302
+379,161
+112% +$13.8M 0.65% 30
2020
Q2
$11.4M Hold
337,141
0.38% 50
2020
Q1
$11.4M Sell
337,141
-8,224
-2% -$329K 0.38% 50
2019
Q4
$16.5M Sell
345,365
-56,199
-14% -$2.72M 0.44% 39
2019
Q3
$20M Sell
401,564
-68,335
-15% -$3.49M 0.45% 60
2019
Q2
$25.1M Hold
469,899
0.54% 44
2019
Q1
$24.8M Sell
469,899
-96,249
-17% -$5.01M 0.57% 42
2018
Q4
$26.6M Sell
566,148
-15,779
-3% -$823K 0.47% 36
2018
Q3
$33.6M Sell
581,927
-10,346
-2% -$573K 0.47% 32
2018
Q2
$32.2M Sell
592,273
-84,120
-12% -$4.17M 0.46% 36
2018
Q1
$32M Buy
+676,393
New +$33.9M 0.46% 36

Other funds holding NTR

Barings's NTR Position: Q1 2026 in Review

Barings increased its Nutrien (NTR) stake by 71% in Q1 2026, buying an estimated $6.38M and bringing the position to 216,325 shares worth $16.3M. The position accounts for 0.26% of the portfolio, ranked #38.

Barings first reported a position in NTR in Q1 2018 and has held it in 33 quarters since. The position peaked at $37.1M in Q1 2023. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Barings held 216,325 shares of Nutrien worth $16.3M as of Q1 2026.
  • Barings bought 89,517 Nutrien shares in Q1 2026, an estimated $6.38M.
  • Nutrien made up 0.26% of Barings's portfolio in Q1 2026, its #38 holding.
  • Barings first reported a position in Nutrien in Q1 2018 and has held it in 33 quarters since.
  • Barings's Nutrien position peaked at $37.1M in Q1 2023.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Barings's 13F filing for Q1 2026, filed 6 May 2026.